Leonil Joelle, Henry Gwenaele, Jouanneau Dianne, Delage Marie-Madeleine, Forge Vincent, Putaux Jean-Luc
INRA, UMR1253 Science et Technologie du Lait et de l'OEuf, F-35000 Rennes, France.
J Mol Biol. 2008 Sep 19;381(5):1267-80. doi: 10.1016/j.jmb.2008.06.064. Epub 2008 Jun 28.
S-carboxymethylated (SCM) kappa-casein forms in vitro fibrils that display several characteristics of amyloid fibrils, although the protein is unrelated to amyloid diseases. In order to get insight into the processes that prevent the formation of amyloid fibrils made of kappa-caseins in milk, we have characterized in detail the reaction and the roles of its possible effectors: glycosylation and other caseins. Given that native kappa-casein occurs as a heterogeneous mixture of carbohydrate-free and carbohydrate-containing chains, kinetics of fibril formation were performed on purified glycosylated and unglycosylated SCM kappa-caseins using the fluorescent dye thioflavin T in conjunction with transmission electron microscopy and Fourier transform infrared spectroscopy for morphological and structural analyses. Both unglycosylated and glycosylated SCM kappa-caseins have the ability to fibrillate. Kinetic data indicate that the fibril formation rate increases with SCM kappa-casein concentration but reaches a plateau at high concentrations, for both the unglycosylated and glycosylated forms. Therefore, a conformational rearrangement is the rate-limiting step in fibril growth of SCM kappa-casein. Transmission electron microscopy images indicate the presence of 10- to 12-nm spherical particles prior to the appearance of amyloid structure. Fourier transform infrared spectroscopy spectra reveal a conformational change within these micellar aggregates during the fibrillation. Fibrils are helical ribbons with a pitch of about 120-130 nm and a width of 10-12 nm. Taken together, these findings suggest a model of aggregation during which the SCM kappa-casein monomer is in rapid equilibrium with a micellar aggregate that subsequently undergoes a conformational rearrangement into a more organized species. These micelles assemble and this leads to the growing of amyloid fibrils. Addition of alpha(s1)-and beta-caseins decreases the growth rate of fibrils. Their main effect was on the elongation rate, which became close to that of the limiting conformation change, leading to the appearance of a lag phase at the beginning of the kinetics.
S-羧甲基化(SCM)κ-酪蛋白在体外形成的纤维具有淀粉样纤维的若干特征,尽管该蛋白质与淀粉样疾病无关。为了深入了解阻止牛奶中κ-酪蛋白形成淀粉样纤维的过程,我们详细表征了该反应及其可能的效应物(糖基化和其他酪蛋白)的作用。鉴于天然κ-酪蛋白以无糖基化和含糖基化链的异质混合物形式存在,我们使用荧光染料硫黄素T结合透射电子显微镜和傅里叶变换红外光谱进行形态和结构分析,对纯化的糖基化和非糖基化SCMκ-酪蛋白的纤维形成动力学进行了研究。非糖基化和糖基化的SCMκ-酪蛋白都有形成纤维的能力。动力学数据表明,对于非糖基化和糖基化形式,纤维形成速率均随SCMκ-酪蛋白浓度增加而增加,但在高浓度时达到平稳状态。因此,构象重排是SCMκ-酪蛋白纤维生长的限速步骤。透射电子显微镜图像表明,在淀粉样结构出现之前存在10至12纳米的球形颗粒。傅里叶变换红外光谱揭示了这些胶束聚集体在纤维化过程中发生的构象变化。纤维是螺距约为120 - 130纳米、宽度为10 - 12纳米的螺旋带。综上所述,这些发现提示了一种聚集模型,在此模型中,SCMκ-酪蛋白单体与胶束聚集体处于快速平衡状态,该聚集体随后经历构象重排形成更有序的物种。这些胶束组装在一起,导致淀粉样纤维的生长。添加α(s1)-和β-酪蛋白会降低纤维的生长速率。它们的主要作用是对伸长率的影响,伸长率变得接近极限构象变化的速率,导致动力学开始时出现滞后阶段。